Improving future treatment options for menopausal symptoms by using genomics to understand aetiology

通过使用基因组学了解病因来改善更年期症状的未来治疗选择

基本信息

  • 批准号:
    MR/Y003780/1
  • 负责人:
  • 金额:
    $ 103.05万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2024
  • 资助国家:
    英国
  • 起止时间:
    2024 至 无数据
  • 项目状态:
    未结题

项目摘要

As women go through menopause, hormone levels change and periods stop. Menopause is often accompanied by symptoms, such as hot flushes/night sweats, disturbed sleep, and mood change. For about 1 in 10 women these symptoms can continue for many years and affect their quality of life, ability to work and mental health. There is currently a great deal of media attention on menopause, prompted by the increasing voice of women, including female celebrities, wanting to highlight its importance and remove taboos. Despite this, research into the symptoms experienced around menopause has been relatively limited. Some advice being offered to women is not always based on robust scientific evidence, such as using testosterone to treat low sex drive and tiredness. Hot flushes can be successfully treated by re-balancing hormone levels with hormone replacement therapy (HRT), but this treatment is not recommended for everyone. Other symptoms seem to be less effectively treated by HRT, for example sleep disturbance. Some women prefer to avoid HRT due to fears regarding side effects including increased risk of breast cancer. Research has not yet studied why women have different symptoms in the menopause, or what causes all of them. We want to answer these questions so that we can find better treatments for symptoms experienced during menopause. Studying differences in our genes provides a unique opportunity to understand the biological processes that cause diseases and health conditions. Finding a genetic link with a condition generally reveals a true cause, because our genes are not changed over our lifetime by the environment or our lifestyle. There are now hundreds of thousands of people who have had genetic data collected in studies across the world and much of this data is available to researchers at minimal cost. These studies also have information about the health and lifestyle of the participants and many also have access to their health records. We have have worked with many of these data sets previously, including a study of more than 200,000 women which helped us understand how the ovary ages. We have also started to use genetics to investigate the causes of menopausal hot flushes in a study of 92,000 women from the UK Biobank. We found a gene that is directly linked to a new treatment that is currently being tested in large clinical trials as an alternative to HRT. This proves our approach works well, so we want to use it to study other symptoms of the menopause.Detailed information about symptoms occuring around menopause in large numbers of individuals is essential to be able to find genetic links. Currently, this information is often not available. Therefore, we will collect information about symptoms that occur during menopause in a standardised way, combining three approaches: (i) develop a bespoke survey to send out to study participants; (ii) use existing information already held by some studies; and (iii) use electronic healthcare records that are linked to study participants. With this approach we expect to have data from over 700,000 women in total, which will maximise the chance of finding new genetic links. We will also make the data we generate available to other researchers to use and build on in the future. For hot flushes we anticipate being able to identify 5-10 new genes that are involved. This will increase our understanding of what causes hot flushes and point us in the direction of new drugs that might be used to treat women who experience them. By understanding the causes of other symptoms we will be able to assess which might be treated by similar drugs, and which will need alternative therapies. The study addresses an important and under-researched area of medicine, of significant concern to women and with important societal implications.
随着女性进入更年期,荷尔蒙水平发生变化,月经停止。更年期通常伴有症状,如潮热/盗汗,睡眠障碍和情绪变化。大约十分之一的妇女,这些症状可以持续多年,影响她们的生活质量、工作能力和心理健康。目前,由于包括女名人在内的女性越来越多的声音,希望强调更年期的重要性并消除禁忌,媒体对更年期给予了大量关注。尽管如此,对更年期症状的研究相对有限。向女性提供的一些建议并不总是基于强有力的科学证据,例如使用睾丸激素来治疗性欲低下和疲劳。潮热可以通过激素替代疗法(HRT)重新平衡激素水平来成功治疗,但这种治疗并不推荐给每个人。其他症状似乎不太有效地治疗HRT,例如睡眠障碍。有些女性更喜欢避免HRT,因为担心副作用,包括增加乳腺癌的风险。研究还没有研究为什么女性在更年期有不同的症状,或者是什么导致了所有这些症状。我们想回答这些问题,以便我们能够找到更好的治疗更年期症状的方法。研究我们基因的差异为了解导致疾病和健康状况的生物过程提供了一个独特的机会。找到一个基因与疾病的联系通常会揭示一个真正的原因,因为我们的基因在我们的一生中不会被环境或我们的生活方式改变。现在,世界各地的研究已经收集了数十万人的遗传数据,其中大部分数据都可以以最低的成本提供给研究人员。这些研究也有关于参与者的健康和生活方式的信息,许多人还可以访问他们的健康记录。我们之前已经研究过许多这样的数据集,包括一项针对20多万名女性的研究,这有助于我们了解卵巢是如何衰老的。我们还开始使用遗传学来调查更年期潮热的原因,这项研究涉及英国生物银行的92,000名女性。我们发现了一个基因,它与一种新的治疗方法直接相关,这种新的治疗方法目前正在大型临床试验中进行测试,作为HRT的替代品。这证明我们的方法效果很好,所以我们想用它来研究更年期的其他症状。大量个体更年期症状的详细信息对于找到遗传联系至关重要。目前,这方面的信息往往无法获得。因此,我们将以标准化的方式收集有关绝经期间发生的症状的信息,结合三种方法:(i)开发一个定制的调查发送给研究参与者;(ii)使用一些研究已经掌握的现有信息;(iii)使用与研究参与者相关的电子医疗记录。通过这种方法,我们预计总共将获得超过70万名女性的数据,这将最大限度地提高发现新遗传联系的机会。我们还将把我们生成的数据提供给其他研究人员,供他们在未来使用和建立。对于潮热,我们预计能够确定5-10个新的基因参与。这将增加我们对潮热原因的理解,并为我们指明可能用于治疗潮热女性的新药的方向。通过了解其他症状的原因,我们将能够评估哪些可以用类似的药物治疗,哪些需要替代疗法。这项研究涉及一个重要的和研究不足的医学领域,对妇女的重大关切和重要的社会影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna Murray其他文献

Whole-genome sequencing analysis identifies rare, large-effect noncoding variants and regulatory regions associated with circulating protein levels
全基因组测序分析确定了与循环蛋白水平相关的罕见、大效应非编码变异和调控区域
  • DOI:
    10.1038/s41588-025-02095-4
  • 发表时间:
    2025-02-24
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Gareth Hawkes;Kartik Chundru;Leigh Jackson;Kashyap A. Patel;Anna Murray;Andrew R. Wood;Caroline F. Wright;Michael N. Weedon;Timothy M. Frayling;Robin N. Beaumont
  • 通讯作者:
    Robin N. Beaumont
Guidance for estimating penetrance of monogenic disease-causing variants in population cohorts
人群队列中单基因致病变异外显率估计的指南
  • DOI:
    10.1038/s41588-024-01842-3
  • 发表时间:
    2024-07-29
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Caroline F. Wright;Luke N. Sharp;Leigh Jackson;Anna Murray;James S. Ware;Daniel G. MacArthur;Heidi L. Rehm;Kashyap A. Patel;Michael N. Weedon
  • 通讯作者:
    Michael N. Weedon
Distribution of FMR1 and FMR2 alleles in Javanese individuals with developmental disability and confirmation of a specific AGG‐interruption pattern in Asian populations
FMR1 和 FMR2 等位基因在爪哇发育障碍个体中的分布以及亚洲人群中特定 AGG 中断模式的确认
  • DOI:
    10.1046/j.1469-1809.2001.6520127.x
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    S. Faradz;J. Leggo;Anna Murray;P. R. L. Lam;Michael F. Buckley;Jeanette J.A. Holden
  • 通讯作者:
    Jeanette J.A. Holden
The home and school background of young drivers involved in traffic accidents.
发生交通事故的年轻驾驶员的家庭和学校背景。
Endovenous laser therapy in the treatment of short saphenous vein disease
  • DOI:
    10.1016/j.carrev.2012.01.027
  • 发表时间:
    2012-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Julien Al Shakarchi;Anna Murray;Aneel Banghu;Ajantha Jayatunga;Rajiv Pathak
  • 通讯作者:
    Rajiv Pathak

Anna Murray的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

面向未来城市的智慧路灯创新设计与技术集成——以重庆科学城示范应用为例
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
地方政府债券支持战略性新兴产业和未来产业的精准赋能体系研究
  • 批准号:
    2025C25003
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
浙江“未来社区”智慧养老数据利用的共享模式与保护政策研究
  • 批准号:
    2025C35007
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
浙江省建立未来产业投入增长机制的路径与对策研究
  • 批准号:
    2025C35054
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
发挥国有资本投资机构在培育未来产业中的生态投资者作用研究
  • 批准号:
    2025C35085
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
创新驱动未来产业发展的机制、路径和对策研究
  • 批准号:
    2025C35110(SYS)
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
湖北省稻虾模式时空演变特征、驱动机制及未来预估
  • 批准号:
    JCZRYB202501262
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
以应用场景创新牵引未来产业发展的思路研究
  • 批准号:
    2025C25054
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
长江流域骤旱生态效应与未来风险预估研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
未来医院建筑发展研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Assessing and Improving the Durability of Compensatory Cognitive Training for Older Veterans (AID-CCT)
评估和提高老年退伍军人补偿性认知训练的持久性 (AID-CCT)
  • 批准号:
    10636523
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Improving Patient-Centered Decision-Making for Stress Urinary Incontinence Treatment in Older Men
改善老年男性压力性尿失禁治疗中以患者为中心的决策
  • 批准号:
    10729838
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Improving our understanding of breast cancer mortality disparities through recurrence: a multi-level approach among women in Georgia
通过复发提高我们对乳腺癌死亡率差异的理解:格鲁吉亚妇女的多层次方法
  • 批准号:
    10818726
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Improving Community-level Bystander Cardiopulmonary Resuscitation in Underserved Populations
改善服务不足人群的社区级旁观者心肺复苏
  • 批准号:
    10738902
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
通过调节肿瘤炎症提高胶质瘤免疫治疗效果
  • 批准号:
    10750788
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Chrono-exercise is Medicine: Improving Blood Pressure and Vascular Function through Chronotherapy
计时运动是良药:通过计时疗法改善血压和血管功能
  • 批准号:
    10658613
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Improving social connectedness through digital health to enhance recovery from OUD among the justice involved population.
通过数字健康改善社会联系,以促进司法相关人群从 OUD 中恢复。
  • 批准号:
    10675916
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Improving the activity of CAR T cells for acute myeloid leukemia
提高CAR T细胞治疗急性髓系白血病的活性
  • 批准号:
    10740585
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Strategy for Improving Stroke Treatment Response (SISTER) Trial
改善中风治疗反应策略 (SISTER) 试验
  • 批准号:
    10595947
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
在首次精神分裂症发作后通过远程医疗有氧运动和认知训练提高认知能力
  • 批准号:
    10647268
  • 财政年份:
    2023
  • 资助金额:
    $ 103.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了